TY - JOUR
AR - JCMCR-2020-2-107
TI - Scoring System for Patients with Cancer to Weigh Risk/Benefit of Chemotherapy During Outbreak of COVID-19
AU - Reyad, Dada
AU - Bassim T. , Malas Al-Beirouti
JO - Journal of Clinical and Medical Case Reports
PY - 2020
DA - Thu 20, Aug 2020
SN - 2733-2268
DO - http://dx.doi.org/10.31487/j.JCMCR.2020.02.07
UR - https://www.sciencerepository.org/scoring-system-for-patients-with-cancer-to-weigh-risk_JCMCR-2020-2-107 
KW - COVID-19, corona virus, cancer treatment
AB - Coronavirus disease 2019 (COVID-19) is impacting our daily practice. Hematologist and oncologist around
the globe are concerned and many physicians are hesitating to start/continue antineoplastic treatment in
patients with cancer to protect them from severe complications in case of infection with the new novel
corona virus. Therefore, we feel there is a high demand for scoring system to guide and help physicians
dealing with patients with malignant diseases to take the correct decision. We have designed a scoring
system to evaluate patients with cancer requiring anti-cancer treatment and we have started to implement it
at our hospital. Therefore, we would like to share this scoring system with the community.